Advertisement

Topics

Oxford Endovascular in GLP phase with its brain aneurysm treatment device

03:55 EST 14 Jan 2019 | Proactive Investors

Oxford Endovascular Limited CEO Mike Karim spoke with Proactive Investors at the Biotech Showcase in San Francisco.

Oxford Endovascular Limited is a spin out from The University of Oxford. The company is developing metallic mesh tube devices invented by engineers and clinicians at the University to treat patients suffering from brain aneurysms.

Original Article: Oxford Endovascular in GLP phase with its brain aneurysm treatment device

NEXT ARTICLE

More From BioPortfolio on "Oxford Endovascular in GLP phase with its brain aneurysm treatment device"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...